{
  "id": 15330996,
  "title": "Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?",
  "url": "https://urgent.news/2026/10/18/cathie-wood-keeps-buying-beam-therapeutics-on-the-dip-should-you-15330996",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-18T01:20:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/cathie-wood-keeps-buying-beam-therapeutics-dip-should-you-follow-her-lead"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsCathie Wood owns Beam shares worth roughly $220 million, at the stock's current price.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?",
        "url": "https://urgent.news/2026/10/18/cathie-wood-keeps-buying-beam-therapeutics-on-the-dip-should-you",
        "published": "2026-10-18T01:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}